ARIAD PHARMACEUTICALS INC's ticker is and the CUSIP is 04033A950. A total of 3 filers reported holding ARIAD PHARMACEUTICALS INC in Q4 2013. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $4,368,000 | -20.5% | 351,100 | -12.5% | 0.04% | -30.0% |
| Q3 2016 | $5,492,000 | +284.6% | 401,200 | +107.7% | 0.06% | +252.9% |
| Q2 2016 | $1,428,000 | +224.5% | 193,200 | +180.4% | 0.02% | +183.3% |
| Q1 2016 | $440,000 | -88.7% | 68,900 | -88.9% | 0.01% | -87.0% |
| Q4 2015 | $3,879,000 | +5.2% | 620,700 | -1.7% | 0.05% | -9.8% |
| Q3 2015 | $3,686,000 | -49.7% | 631,200 | -28.7% | 0.05% | -50.0% |
| Q2 2015 | $7,322,000 | +13.3% | 885,400 | +12.9% | 0.10% | +1.0% |
| Q1 2015 | $6,461,000 | -29.2% | 784,100 | -40.9% | 0.10% | -26.8% |
| Q4 2014 | $9,122,000 | +104.6% | 1,327,800 | +60.8% | 0.14% | +100.0% |
| Q3 2014 | $4,459,000 | -12.3% | 825,800 | +3.5% | 0.07% | -11.5% |
| Q2 2014 | $5,083,000 | -54.2% | 798,000 | -42.1% | 0.08% | -58.3% |
| Q1 2014 | $11,102,000 | -6.9% | 1,377,400 | -21.2% | 0.19% | +3.9% |
| Q4 2013 | $11,927,000 | +205.5% | 1,748,800 | +724.1% | 0.18% | +140.0% |
| Q3 2013 | $3,904,000 | +156.8% | 212,200 | +144.2% | 0.08% | +102.7% |
| Q2 2013 | $1,520,000 | – | 86,900 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GROUP ONE TRADING, L.P. | 1,748,800 | $11,927,000 | 0.18% |
| SABBY MANAGEMENT, LLC | 2,309 | $1,575,000 | 0.10% |
| Citadel Advisors | 383,400 | $2,615,000 | 0.00% |